Patent Transactions 2024. PowerPatent Issued Patent. Powerful Idea. SaaS Conference and PowerPatent. USPTO PowerPatent Semin ...

Thiogenesis Therapeutics, Inc. (TSXV: TTI) (OTCQX: TTIPF), a clinical-stage biopharmaceutical company developing next-generation thiol-based therapies for mitochondrial disease and pediatric metabolic ...

Submission Seeks Approval of GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) Comprehensive Data Package ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they have obtained Japan Country Patent No. 7677628 for the ...

OCALA, Fla., June 12, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (OTC Pink: AIMID) (“AIM” or the “Company”) today announced the United States Patent and Trademark Office has ...

SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company engaged in developing transportation safety solutions, is pleased to announce the award by the United States Patent and Trademark ...

Some companies provide an online form to use to submit your form. The Ford form asks for a summary of your new idea in 300 characters or less along with a detailed description outlining how your ...

A bipartisan group of lawmakers on Wednesday vowed to keep Chinese artificial intelligence systems out of federal agencies while pledging to ensure the U.S. will prevail against China in the global ...

National Institute of Food Technology Entrepreneurship and Management (NIFTEM), Plot No. 97, Sector 56, HSIIDC Industrial ...

The recent commercial re-launch of LIKMEZ® (ATI-1501), following new patent coverage through to 2039, marked a major milestone for Appili and our partner, Saptalis Pharmaceuticals, LLC (“Saptalis”).

AD04 is Adial's lead investigational drug, a serotonin-3 receptor antagonist, being developed for the treatment of Alcohol ...